Keypoints:
- Kenya-UAE health ties are shifting towards investment and technology transfer
- Digital health, maternal care and local manufacturing offer major opportunities
- Kenya must secure transparency, skills transfer and lasting local benefits
I HAVE followed Kenya’s healthcare journey for years, and the challenges confronting the country today are far more than statistics on a page.
They are stories of mothers and newborns dying from preventable complications, families struggling to finance cancer treatment, patients travelling long distances in search of essential medicines, and health workers trying to deliver care in facilities that are understaffed or poorly equipped.
These are human problems, and they demand solutions that ultimately improve the lives of patients.
Kenya has made considerable progress in expanding access to healthcare, but significant gaps remain in financing, infrastructure, specialised care, medical technology, medicines and human resources. These pressures are becoming more urgent as the population grows and the burden of non-communicable diseases such as cancer, diabetes and cardiovascular disease increases.
Against this backdrop, the expanding relationship between Kenya and the United Arab Emirates presents an opportunity that deserves greater attention.
A partnership moving beyond diplomacy
Healthcare cooperation between Kenya and the UAE is already developing beyond diplomatic statements.
In January 2025, Kenya’s Ministry of Health said officials from the two countries were following up on an existing Memorandum of Understanding aimed at deepening cooperation in healthcare.
Discussions covered vaccine production, the expansion of primary healthcare through the Community Health Promoters programme, and efforts to strengthen universal health coverage by improving the availability of essential health products and technologies.
These are precisely the areas in which Kenya needs sustained investment.
But partnerships of this nature should not be judged by the number of agreements signed or delegations exchanged. Their real value will be determined by whether they help Kenya develop lasting capacity to finance, manufacture, distribute and deliver healthcare more effectively.
Digital investment could transform care
Digital transformation provides another important area for cooperation, although recent investment announcements must be viewed with some caution.
In May 2024, Microsoft and UAE-based artificial intelligence company G42 announced a $1bn investment centred on developing cloud and data infrastructure in Kenya.
The proposed investment was potentially significant for Kenya’s wider digital ecosystem and could eventually provide important foundations for digital public services, including healthcare.
However, the project has not progressed as originally envisaged.
Reuters reported in May 2026 that the data-centre project had encountered delays amid disagreements over proposed capacity payments and the scale of power requirements. Kenyan officials said the initiative had not been cancelled and that discussions were continuing.
That experience offers an important lesson. Major investment announcements should be treated as starting points rather than outcomes.
Separately, the UAE launched a $1bn ‘AI for Development’ initiative in November 2025 to finance artificial intelligence projects across African countries.
The initiative is intended to support economic and social development through digital infrastructure, government services and productivity, with education, agriculture and infrastructure among the sectors specifically identified for AI deployment.
UAE officials have also pointed to healthcare as one of the development needs facing African countries that could benefit from technological transformation.
Kenya should make a strong case for health projects capable of attracting investment under these emerging initiatives.
Artificial intelligence could support diagnostics, disease surveillance, hospital management, remote consultations and clinical decision-making. Electronic medical records and interoperable systems could improve continuity of care and reduce duplication.
For Kenya’s growing health-tech sector, deeper cooperation with UAE investors could also provide capital, technical expertise and routes to international markets.
The objective, however, should not simply be to import technology. Kenya must build local expertise capable of developing, adapting, managing and regulating these systems.
Maternal health shows what is possible
Cooperation on maternal and newborn health demonstrates how international partnerships can reinforce national healthcare priorities.
In August 2026, Kenya’s Ministry of Health announced a five-year partnership with the Beginnings Fund backed by $80m, approximately Sh10.4bn, to accelerate maternal and newborn health reforms.
The programme targets 21 high-burden counties and nearly 200 high-volume health facilities. It is expected to benefit close to six million women and newborns by 2030.
Investment will go towards the health workforce, essential medicines and technologies, referral systems and health information infrastructure, while supporting reforms already being pursued by the Kenyan government.
The UAE has a particularly important connection to the wider initiative.
The Mohamed bin Zayed Foundation for Humanity provided a $125m grant supporting the creation of the Beginnings Fund and related maternal and newborn health initiatives. That commitment helped unlock matched contributions from other philanthropic organisations as part of a much larger international financing effort.
For Kenya, the important principle is that external financing should reinforce national and county health systems rather than create parallel structures that disappear when funding ends.
Essential medicines bring immediate relief
Another tangible example of cooperation came in April 2026, when the UAE donated a major consignment of essential medicines to Kenya.
The supplies included treatments used for hypertension, diabetes, bacterial infections and respiratory conditions.
The Kenya Medical Supplies Authority moved to distribute the medicines across all 47 counties, with a target of completing delivery within 10 days.
According to KEMSA, it was the first time the UAE had entrusted the authority with nationwide distribution of a donation of that scale.
For someone seeking treatment at a rural health centre, this matters enormously.
Access to medicines can determine whether a person living with diabetes or hypertension continues treatment or goes without it. For an overstretched health worker, a well-stocked pharmacy can mean the difference between treating someone immediately and sending that person elsewhere in search of medicine.
Donations can therefore provide vital and sometimes life-saving relief.
But donations alone cannot build a resilient healthcare system.
From donations to durable capacity
Kenya has considerable expertise in digital health, mobile technology, community healthcare and last-mile service delivery.
The UAE, meanwhile, has developed substantial capabilities in healthcare infrastructure, advanced medical technology, investment and digital transformation.
The opportunity should therefore not be framed as one country giving and another receiving.
Both sides have something to bring to the table.
For the UAE, Kenya offers a strategic gateway into East Africa, a growing population, an established technology ecosystem and significant unmet healthcare demand.
Investment in hospitals, pharmaceutical manufacturing, diagnostics, medical technology, health logistics and digital health could create commercial opportunities while contributing to improved health outcomes.
For Kenya, such investment could reduce dependence on imports, build specialist expertise, create employment and improve access to care.
The relationship becomes more valuable when it moves beyond philanthropy towards genuine economic, technological and knowledge-sharing partnerships.
Local manufacturing should come next
Vaccine and pharmaceutical manufacturing should be high on the agenda.
Kenya has already identified local vaccine production as a national priority, with the government seeking to develop domestic manufacturing capacity and reduce reliance on imported supplies.
The Covid-19 pandemic demonstrated what can happen when African countries depend overwhelmingly on manufacturing capacity and supply chains located elsewhere.
Greater local production would strengthen Kenya’s health security, reduce vulnerability to international supply disruptions and create highly skilled employment.
UAE investors and healthcare institutions could contribute financing, technology, research partnerships, technical expertise and access to international markets.
Cooperation could extend beyond vaccines into pharmaceuticals, diagnostics, cold-chain infrastructure, medical equipment and biotechnology.
Training must be part of that process.
Investment in sophisticated hospitals, artificial intelligence platforms or digital systems will produce limited benefits unless Kenya has enough doctors, nurses, pharmacists, laboratory specialists, biomedical engineers and technology professionals to operate and sustain them.
Meaningful knowledge and technology transfer should therefore be built into major partnerships from the beginning.
Kenya must protect the public interest
Greater investment should not mean weaker scrutiny.
Healthcare partnerships involving digital platforms and artificial intelligence raise important questions about patient privacy, ownership of health data, cybersecurity, procurement and accountability.
Kenya must ensure that partnerships involving foreign investors provide measurable local benefits, operate under transparent procurement arrangements and comply with strong safeguards for sensitive patient information.
Technology transfer should also be real rather than rhetorical.
If systems are installed but can only be operated, repaired or upgraded by foreign providers, Kenya risks replacing one form of dependence with another.
A sustainable partnership should leave behind institutions, expertise and infrastructure that Kenya can increasingly manage itself.
Success must be measured in patients
Kenya and the UAE now have an opportunity to build something more ambitious than a collection of individual health projects.
The foundations are increasingly visible: cooperation on primary healthcare, maternal and newborn health, essential medicines, digital infrastructure, artificial intelligence and the possibility of greater local manufacturing.
The next challenge is connecting these initiatives into a coherent long-term strategy.
Kenya should be clear about the capabilities it wants to build. The UAE, for its part, can view the country not simply as a recipient of assistance but as an investment and innovation partner capable of serving the wider East African market.
Ultimately, however, the success of this relationship should not be measured by the value of announcements or the number of agreements signed.
It should be measured by whether a mother can reach safe maternity care in time, whether a patient with diabetes can obtain medicine close to home, whether a rural clinician can access specialist support through digital technology, and whether Kenya can produce more of the medicines and technologies its people depend upon.
If Kenya and the UAE keep the patient — rather than the policy announcement — at the centre of their cooperation, they can build a healthcare partnership measured not by promises, but by lives saved, families protected and communities given a better chance at a healthier future.
Zachary Ochieng is a Global Communications Strategist with experience advising organisations in the healthcare sector
